Focused Ultrasound for Twin-Twin Transfusion Syndrome
Quick Facts
What is twin-twin transfusion syndrome?
Twin-twin transfusion syndrome is a potentially life-threatening complication of monochorionic twin pregnancies, in which twins share one placenta. Abnormal connections between placental blood vessels can cause one fetus, known as the donor twin, to send more blood to the other, the recipient twin. This imbalance can lead to too little amniotic fluid around one twin and excess fluid around the other.
Without specialist assessment and treatment when indicated, severe TTTS can endanger both fetuses and the pregnant patient. Care is typically coordinated through a fetal medicine center, where clinicians use ultrasound to assess amniotic fluid, fetal bladders, blood flow and fetal heart function. Management depends on gestational age and disease severity.
How could focused ultrasound treat TTTS?
The experimental approach described in the recent Medical Xpress report uses concentrated high-energy sound waves. In principle, focused ultrasound can deliver energy to a selected internal target while limiting injury to surrounding tissue, but its use in TTTS must be evaluated carefully because the placenta, uterus and fetuses are highly sensitive treatment targets.
Current standard treatment for severe TTTS is fetoscopic laser photocoagulation, in which a specialist uses a small scope to identify and seal connecting placental vessels. A non-invasive approach could eventually reduce the need for uterine entry if it proves accurate, effective and safe in rigorous clinical studies. Early safety findings are encouraging but cannot establish long-term pregnancy outcomes or equivalence to laser therapy.
Should pregnant patients expect this treatment now?
Patients should not delay established assessment or treatment while waiting for an experimental option. Warning signs are not reliable enough for home diagnosis, so people carrying monochorionic twins should attend recommended ultrasound surveillance and promptly discuss symptoms such as rapid abdominal enlargement, pain, contractions or shortness of breath with their maternity team.
The key next research questions are whether focused ultrasound can consistently close the relevant vessel connections, whether it improves survival and neurologic outcomes, and whether it causes unintended placental or fetal effects. Trials will need to compare the procedure with contemporary fetoscopic laser care and follow infants after birth.
Frequently Asked Questions
No. TTTS is a complication that can occur when twins share a placenta, most often monochorionic identical twins. Many twin pregnancies do not develop TTTS.
Fetoscopic laser photocoagulation is the established treatment for many severe cases, particularly when diagnosed during the usual treatment window. Individual decisions require assessment by a fetal medicine specialist.
The reported procedure is experimental. Patients should ask their maternal-fetal medicine team about evidence-based care and whether any appropriately regulated clinical studies are available.
References
- Medical Xpress. New non-invasive treatment shows promise for twin pregnancy complications. July 2026.
- Senat MV, et al. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. The New England Journal of Medicine. 2004.